Team:Freiburg bioware/Project/clonestrat

From 2009.igem.org

(Difference between revisions)
 
(12 intermediate revisions not shown)
Line 1: Line 1:
-
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en"
+
<html xmlns="http://www.w3.org/1999/xhtml" dir="ltr"
-
  dir="ltr" lang="en-US">
+
  lang="en-US">
<head>
<head>
-
   <meta http-equiv="Content-Type"
+
   <meta content="text/html; charset=UTF-8"
-
content="text/html; charset=UTF-8" />
+
http-equiv="Content-Type" />
-
   <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" />
+
   <meta content="IE=EmulateIE7" http-equiv="X-UA-Compatible" />
   <title>FREiGEM</title>
   <title>FREiGEM</title>
-
   <script type="text/javascript" src="script.js"></script>
+
   <script src="script.js" type="text/javascript"></script>
-
   <link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css"
+
   <link media="screen" type="text/css" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css"
-
  type="text/css" media="screen" />
+
  rel="stylesheet" />
<!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style_ie7.css&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]-->
<!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style_ie7.css&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]-->
</head>
</head>
Line 32: Line 32:
<div class="r"></div>
<div class="r"></div>
<ul class="art-menu">
<ul class="art-menu">
-
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware"
+
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware"><span
-
class="active"><span class="l"></span><span
+
class="l"></span><span class="r"></span><span
-
class="r"></span><span class="t">Home</span></a></li>
+
class="t">Home</span></a></li>
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span
   <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
Line 45: Line 45:
     </ul>
     </ul>
   </li>
   </li>
-
   <li><a
+
   <li><a class="active"
  href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span
  href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
Line 54: Line 54:
  href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a>
  href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a>
       </li>
       </li>
 +
   
       <li><a
       <li><a
  href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li>
  href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li>
Line 71: Line 72:
     </ul>
     </ul>
   </li>
   </li>
-
   <li><a
+
   <li><a href="#"><span class="l"></span><span
-
href="https://2009.igem.org/Team:Freiburg_bioware/Notebook"><span
+
class="r"></span><span class="t">Notebook</span></a></li>
-
class="l"></span><span class="r"></span><span
+
-
class="t">Notebook</span></a></li>
+
   <li><a
   <li><a
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><span
  href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"><span
Line 95: Line 94:
  href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span
  href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
-
  class="t">Modeling</span></a></li>
+
  class="t">Modeling</span></a> </li>
</ul>
</ul>
</div>
</div>
Line 124: Line 123:
<b>Introduction</b><br><br>
<b>Introduction</b><br><br>
-
Freiburg standard<br>
+
<u>Freiburg standard</u><br>
Cloning with the conventional iGEM Biobrick Standard (RFC 10) does not allow the cloning of fusion proteins because a stop codon is inserted between the fused parts. Thus the Freiburg standard (RFC 25) was established by Kristian Müller, Katja Arndt and Raik Gruenberg in 2007 by adding the AgeI and NgoMIV restriction sites. This enables cloning of in-frame fusion proteins.<br><br>
Cloning with the conventional iGEM Biobrick Standard (RFC 10) does not allow the cloning of fusion proteins because a stop codon is inserted between the fused parts. Thus the Freiburg standard (RFC 25) was established by Kristian Müller, Katja Arndt and Raik Gruenberg in 2007 by adding the AgeI and NgoMIV restriction sites. This enables cloning of in-frame fusion proteins.<br><br>
-
<b>expression vector</b><br><br>
+
<b>Expression vector</b><br><br>
-
pEx Vector <br>
+
<u>pEx Vector</u> <br>
As we needed a suitable expression vector, we altered the NEB vector pMAL-p5x according to our needs. Via PCR the chloramphenicol acetyle transferase (CAT) was amplified out of a lab vector. Add-on-tail primers were used for the PCR containing the prefix XbaI and NgoMIV and the suffix AgeI, SpeI, NotI and PstI. EcoRI and NotI were excluded so that the ribosome binding site (RBS) stays within a distance of 7 nucleotides from the start codon. The add-on-tail primers also included the RBS GAAA ressembling the highly efficient shine dalgarno sequence of Biobrick part: BBa_B0030. In front of the prefix MfeI and behind the suffix HindIII were inserted to enable the exchange of the MalE gene with the CAT gene.
As we needed a suitable expression vector, we altered the NEB vector pMAL-p5x according to our needs. Via PCR the chloramphenicol acetyle transferase (CAT) was amplified out of a lab vector. Add-on-tail primers were used for the PCR containing the prefix XbaI and NgoMIV and the suffix AgeI, SpeI, NotI and PstI. EcoRI and NotI were excluded so that the ribosome binding site (RBS) stays within a distance of 7 nucleotides from the start codon. The add-on-tail primers also included the RBS GAAA ressembling the highly efficient shine dalgarno sequence of Biobrick part: BBa_B0030. In front of the prefix MfeI and behind the suffix HindIII were inserted to enable the exchange of the MalE gene with the CAT gene.
[[image:Freiburg09_Cloningstr1.jpg|Fig1. pEX Vector|300x300px]]<br><br>
[[image:Freiburg09_Cloningstr1.jpg|Fig1. pEX Vector|300x300px]]<br><br>
-
pJS418 and pJS419 Vectors<br>
+
<u>pJS418 and pJS419 Vectors</u><br>
To perform a co-transformation it is neccessary to use vectors with different antibiotica resistence genes.
To perform a co-transformation it is neccessary to use vectors with different antibiotica resistence genes.
The two pJS vectors were suitable because they both carry the CAT gene which provides the bacteria with a chloramphenicole resistence whereas the expression vector pEx includes a ampicilin resistence gene.  
The two pJS vectors were suitable because they both carry the CAT gene which provides the bacteria with a chloramphenicole resistence whereas the expression vector pEx includes a ampicilin resistence gene.  
Another reason why we choose the pJS vectors are the differently strong Shine-Dalgarno sequences. The Fok_a constructs were hard to express in E. coli so we needed a vector with a weak RBS. pJS419 is the vector who fits to that, so we were able to transform and proliferate Fok_A in this vector. pJS419 is inducible by IPTG, like pEX, another reason to pick them for the co-transformation.<br><br>
Another reason why we choose the pJS vectors are the differently strong Shine-Dalgarno sequences. The Fok_a constructs were hard to express in E. coli so we needed a vector with a weak RBS. pJS419 is the vector who fits to that, so we were able to transform and proliferate Fok_A in this vector. pJS419 is inducible by IPTG, like pEX, another reason to pick them for the co-transformation.<br><br>
-
pBAD Vector<br>
+
<u>pBAD Vector</u><br>
The pBAD vector enables the cloning of parts that already contain a ribosome binding site as the vector itself has none. The vector carries a ampicilin resistance gene.<br><br>
The pBAD vector enables the cloning of parts that already contain a ribosome binding site as the vector itself has none. The vector carries a ampicilin resistance gene.<br><br>
<b>Cloning strategy<br></b>
<b>Cloning strategy<br></b>
-
The basic parts were ordered from Mr.Gene or used from last years Freiburg iGEM team (also from Mr.Gene) and were delivered in the vector pMA (Link????) which is fully compatible to RFC 10 and RFC 25. The vector carries a ampicilin resistence gene and an E. coli ori. To avoid ligations with small parts like Tags or linkers, we adapted our cloning strategy. Thus we always cut out the larger inserts with NgoMIV and PstI, whereas vectors with smaller inserts were cut open with AgeI and PstI.  
+
The basic parts were ordered from Mr.Gene or used from last years Freiburg iGEM team (also from Mr.Gene) and were delivered in the vector pMA (<partinfo>BBa_K243031</partinfo>) which is fully compatible to RFC 10 and RFC 25. The vector carries a ampicilin resistence gene and an E. coli ori. To avoid ligations with small parts like Tags or linkers, we adapted our cloning strategy. Thus we always cut out the larger inserts with NgoMIV and PstI, whereas vectors with smaller inserts were cut open with AgeI and PstI.  
As first step we joined tags and binding proteins in one pMA vector and linker and Fok constructs in another pMA respectively.  
As first step we joined tags and binding proteins in one pMA vector and linker and Fok constructs in another pMA respectively.  
-
In the second step the tag-binding_protein was cloned into the expression vector pEx followed in the third step by linker-Fok construct.
+
In the second step the tag-binding_protein was cloned into the expression vector pEx (Vector and Insert XbaI PstI) followed in the third step by the linker-Fok construct.
-
Triple ligations were used to accelerate the cloning process. Therefore the vector was cut open with XbaI and NgoMIV, insert one was cut with XbaI and AgeI and the second insert with NgoMIV and AgeI. The strategy requires a ....
+
<br><br>
<br><br>
 +
<center>
<table>
<table>
<tbody>
<tbody>
Line 160: Line 159:
</table>
</table>
-
<br>
+
 
<table>
<table>
<tbody>
<tbody>
Line 175: Line 174:
<tbody>
<tbody>
<tr>
<tr>
-
       <td><img style="width: 620px; height: 400px;"
+
       <td><img style="width: 600px; height: 400px;"
  alt=""
  alt=""
  src="https://static.igem.org/mediawiki/2009/3/37/Freiburg_09_cl_pEXpart12.jpg" /></td>
  src="https://static.igem.org/mediawiki/2009/3/37/Freiburg_09_cl_pEXpart12.jpg" /></td>
Line 182: Line 181:
</table>
</table>
-
<br>
+
 
<table>
<table>
<tbody>
<tbody>
<tr>
<tr>
-
       <td><img style="width: 330px; height: 280px;"
+
       <td><img style="width: 310px; height: 280px;"
  alt=""
  alt=""
  src="https://static.igem.org/mediawiki/2009/9/9c/Freiburg_09_cl_pEXpart12_complete.jpg" /></td>
  src="https://static.igem.org/mediawiki/2009/9/9c/Freiburg_09_cl_pEXpart12_complete.jpg" /></td>
Line 197: Line 196:
<tbody>
<tbody>
<tr>
<tr>
-
       <td><img style="width: 620px; height: 400px;"
+
       <td><img style="width: 600px; height: 400px;"
  alt=""
  alt=""
  src="https://static.igem.org/mediawiki/2009/0/08/Freiburg_09_cl_part34.jpg" /></td>
  src="https://static.igem.org/mediawiki/2009/0/08/Freiburg_09_cl_part34.jpg" /></td>
Line 204: Line 203:
</table>
</table>
-
<br>
+
 
<table>
<table>
<tbody>
<tbody>
Line 226: Line 225:
</table>
</table>
-
<br>
+
 
<table>
<table>
<tbody>
<tbody>
<tr>
<tr>
-
       <td><img style="width: 320px; height: 280px;"
+
       <td><img style="width: 300px; height: 280px;"
  alt=""
  alt=""
  src="https://static.igem.org/mediawiki/2009/1/16/Freiburg_09_cl_part1234_complete.jpg" /></td>
  src="https://static.igem.org/mediawiki/2009/1/16/Freiburg_09_cl_part1234_complete.jpg" /></td>
Line 241: Line 240:
<tbody>
<tbody>
<tr>
<tr>
-
       <td><img style="width: 600px; height: 400px;"
+
       <td><img style="width: 580px; height: 400px;"
  alt=""
  alt=""
  src="https://static.igem.org/mediawiki/2009/e/e9/Freiburg_09_cl_DsbA_part1234.jpg" /></td>
  src="https://static.igem.org/mediawiki/2009/e/e9/Freiburg_09_cl_DsbA_part1234.jpg" /></td>
Line 248: Line 247:
</table>
</table>
-
<br>
+
 
<table>
<table>
<tbody>
<tbody>
Line 258: Line 257:
</tbody>
</tbody>
</table>
</table>
-
 

Latest revision as of 03:05, 22 October 2009

FREiGEM


Introduction

Freiburg standard
Cloning with the conventional iGEM Biobrick Standard (RFC 10) does not allow the cloning of fusion proteins because a stop codon is inserted between the fused parts. Thus the Freiburg standard (RFC 25) was established by Kristian Müller, Katja Arndt and Raik Gruenberg in 2007 by adding the AgeI and NgoMIV restriction sites. This enables cloning of in-frame fusion proteins.

Expression vector

pEx Vector
As we needed a suitable expression vector, we altered the NEB vector pMAL-p5x according to our needs. Via PCR the chloramphenicol acetyle transferase (CAT) was amplified out of a lab vector. Add-on-tail primers were used for the PCR containing the prefix XbaI and NgoMIV and the suffix AgeI, SpeI, NotI and PstI. EcoRI and NotI were excluded so that the ribosome binding site (RBS) stays within a distance of 7 nucleotides from the start codon. The add-on-tail primers also included the RBS GAAA ressembling the highly efficient shine dalgarno sequence of Biobrick part: BBa_B0030. In front of the prefix MfeI and behind the suffix HindIII were inserted to enable the exchange of the MalE gene with the CAT gene. [[image:Freiburg09_Cloningstr1.jpg|Fig1. pEX Vector|300x300px]]

pJS418 and pJS419 Vectors
To perform a co-transformation it is neccessary to use vectors with different antibiotica resistence genes. The two pJS vectors were suitable because they both carry the CAT gene which provides the bacteria with a chloramphenicole resistence whereas the expression vector pEx includes a ampicilin resistence gene. Another reason why we choose the pJS vectors are the differently strong Shine-Dalgarno sequences. The Fok_a constructs were hard to express in E. coli so we needed a vector with a weak RBS. pJS419 is the vector who fits to that, so we were able to transform and proliferate Fok_A in this vector. pJS419 is inducible by IPTG, like pEX, another reason to pick them for the co-transformation.

pBAD Vector
The pBAD vector enables the cloning of parts that already contain a ribosome binding site as the vector itself has none. The vector carries a ampicilin resistance gene.

Cloning strategy
The basic parts were ordered from Mr.Gene or used from last years Freiburg iGEM team (also from Mr.Gene) and were delivered in the vector pMA (BBa_K243031) which is fully compatible to RFC 10 and RFC 25. The vector carries a ampicilin resistence gene and an E. coli ori. To avoid ligations with small parts like Tags or linkers, we adapted our cloning strategy. Thus we always cut out the larger inserts with NgoMIV and PstI, whereas vectors with smaller inserts were cut open with AgeI and PstI. As first step we joined tags and binding proteins in one pMA vector and linker and Fok constructs in another pMA respectively. In the second step the tag-binding_protein was cloned into the expression vector pEx (Vector and Insert XbaI PstI) followed in the third step by the linker-Fok construct.